ThetaPal ThetaPal

Manufacturing / Pharmaceutical Preparations

CAPRICOR THERAPEUTICS, INC.

CAPR

$7.85

-$0.18 (-2.25%)

Price as of Oct 9, 2026 21:10 UTC

400 M

Market Cap (Small Cap)

53%

IV Rank

269.9%

Implied Volatility

Nov 09

Next Earnings

Technical Signals as of Oct 7
Bearish
0 of 7

Trend

  • Above 20-day average $8.61
  • Above 50-day average $10.35
  • Above 200-day average $22.41 · -63.9%
  • Moving averages stacked Not aligned

Momentum

  • Golden cross (50/200) —
  • Momentum cross (20/50) Down · 95d ago

Volume

  • Below-average volume 0.8x avg

Price & Trend

Daily candles with EMA 20, SMA 50. Drag to zoom.

Options Activity & Greeks

Implied volatility, flow, and dealer positioning from the options market.

Put/Call Ratio

0.51

Bullish skew

Implied Volatility

269.9%

1% percentile

IV vs Realized

Options rich

30d HV 77.4%

Options Heat Map

Delta-risk grid for CAPR options across strikes and expirations. Hover any cell for full Greeks.

Loading option chain data...

Insider Trades

0 buys 11 sells
Date Insider Title Type Shares Value Since Trade
Jun 24, 2026 Bergmann Anthony Sell 400 $12,000 -73.3%
Jun 24, 2026 Bergmann Anthony Exercise 400 $1,272 +151.9%
Jun 24, 2026 Krasney Karen Sell 400 $12,000 -73.3%
Jun 24, 2026 Krasney Karen Exercise 400 $1,272 +151.9%
Jun 24, 2026 Bergmann Anthony Exercise 400 $0 -72.9%
Jun 24, 2026 Krasney Karen Exercise 400 $0 -72.9%
Jun 22, 2026 Bergmann Anthony Exercise 500 $0 -72.7%
Jun 22, 2026 Bergmann Anthony Sell 500 $15,000 -73.3%
Jun 22, 2026 Krasney Karen Exercise 500 $0 -72.7%
Jun 22, 2026 Krasney Karen Sell 500 $15,000 -73.3%

Earnings History

Date Quarter EPS Est. EPS Actual Surprise Result
Aug 13, 2026 Q2 2026 -$0.60
Aug 10, 2026 Q2 2026 -$0.60
Jun 30, 2026 Q2 2026 -$0.60 -$0.70 -16.3% Miss
Mar 31, 2026 Q1 2026 -$0.54 -$0.59 -8.8% Miss
Dec 31, 2025 Q4 2025 -$0.55 -$0.62 -12.6% Miss
Sep 30, 2025 Q3 2025 -$0.56 -$0.54 +3.3% Beat

Track CAPR with ThetaPal

Get insider trade alerts, AI portfolio analysis, and options roll recommendations for CAPR and your entire portfolio.